Addex TherapeuticsADXN
13F holders, Q1 2024 (March 31)1holders
$12.80avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Addex Therapeutics Ltd. (ADXN) in their 13F filings. The largest holder was ADAR1 Capital Management, LLC ($5K).
- Company
- Addex Therapeutics Ltd.
- CUSIP
- 00654J206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $5K |
| Exits | 3 | $717K |
Ownership 1 holders
| ADAR1 Capital Management, LLC | 0.00% | New | 390 | $5K |
"% of holder's portfolio" is ADXN's weight in each manager's 13F, not the share of Addex Therapeutics Ltd. the manager owns.